Search Login Register
Daunorubicin
(Cerubidine)
Summary
Description:
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.
Also Known As:
Cerubidine; Dauno-Rubidomycine; Daunoblastin; Daunoblastine; Daunorubicin Hydrochloride Show All >>
Networked: 1964
relevant articles (179 outcomes,
307 trials/studies)
for this Drug
Key Diseases for which Daunorubicin is
Relevant
-
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
:
70 outcomes 90 studies in 400 results
-
Neoplasms (Cancer)
:
30 outcomes 52 studies in 443 results
-
Leukemia
:
23 outcomes 71 studies in 381 results
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
:
12 outcomes 17 studies in 108 results
-
Acute Promyelocytic Leukemia
:
6 outcomes 3 studies in 44 results
Show All >>
Drugs Related to Daunorubicin
-
Cytarabine (Cytosar-U)
-
Vincristine (Oncovin)
-
Doxorubicin (Adriamycin)
-
Thioguanine (Tioguanine)
-
Idarubicin (4 Demethoxydaunorubicin)
-
Prednisone (Sone)
-
Etoposide (VP 16)
-
Mitoxantrone (Novantrone)
-
Prednisolone (Predate)
-
Daunorubicin (Cerubidine)
Show All >>
Therapies Related to Daunorubicin
-
Drug Therapy (Chemotherapy)
-
Remission Induction
-
Combination Drug Therapy (Combination Chemotherapy)
-
Radiotherapy
-
Heterologous Transplantation (Xenotransplantation)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.